Cargando…
Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France
Autores principales: | Zedan, Hadeel T., Nasrallah, Gheyath K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435264/ https://www.ncbi.nlm.nih.gov/pubmed/34525435 http://dx.doi.org/10.1016/j.ebiom.2021.103580 |
Ejemplares similares
-
Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?
por: Nasrallah, Gheyath K.
Publicado: (2022) -
Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022) -
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
por: Woudenberg, Tom, et al.
Publicado: (2021) -
Human herpes simplex virus-6 (HHV-6) detection and seroprevalence among Qatari nationals and immigrants residing in Qatar
por: Al-Sadeq, Duaa W., et al.
Publicado: (2021) -
Estimating seroprevalence of herpes simplex virus type 1 among different Middle East and North African male populations residing in Qatar
por: Nasrallah, Gheyath K., et al.
Publicado: (2017)